Thursday, September 12th
Friday, September 13th
Saturday, September 14th
Thursday, September 12th
08.00
Opening of the registration desk
08.45
Welcome address
SESSION I – BIOLOGY OF DC SUBSETS
Chairs: Elodie Segura & Marc Dalod
09.00
Dendritic cells: central players in orchestration of Type 2 inflammation – Andrew MacDonald (United Kingdom)
09.30
CO-01-1
NK cells orchestrate the migratory behavior of conventional type 1 dendritic cells to potentiate T cell priming – Karine Crozat (France)
09.42
CO-02-1
High fat diet modulates conventional dendritic cell development through Interferon regulatory factor 8 – Mohamed Ibrahim (Germany)
09.54
CO-03-1
Intestinal mesenchymal cells induce the differentiation of pre-cDCs into CD103+ CD11b+ DCs ex vivo – Verena Kästele (United Kingdom)
10.06
Studies on the heterogeneity and specification of intestinal mononuclear phagocytes – William Agace (Sweden)
10.36
Coffee break and poster viewing
11.00
Decoding human fetal liver haematopoiesis – Muzlifah Haniffa (United Kingdom)
11.30
CO-04-1
Microbiota-associated myeloid TNF production dictates the balance between tolerogenic and protective neonatal pre-cDC1 – Arnaud Köhler (Belgium)
11.42
CO-05-1
Unique cellular sources of CXCR3 ligands direct intranodal T cell positioning and interactions following viral infection – Fanny Lafouresse (Australia)
11.54
CO-06-1
IRF8 is required for maintaining the lineage identity, but not survival, of type 1 conventional dendritic cells – Telma Lanca (Denmark)
12.06
Plasmacytoid dendritic cells, when origin matters – Roxane Tussiwand (USA)
12.36
Lunch and poster viewing
SESSION II – HOST PATHOGEN INTERACTION
Chairs: Bénédicte Manoury & Jean-Pierre Gorvel
14.00
Tuberculosis exacerbates HIV infection in macrophages through tunneling nanotube formation – Olivier Neyrolles (France)
14.30
CO-07-2
Analysis of the response of human primary blood DC (pre-DC) upon HIV-1 infection at the single-cell level – Flavien Brouiller (France)
14.42
CO-08-2
Pathogen recognition through TLR versus NOD receptors has opposite effects on monocyte fate decision – Alice Coillard (France)
14.54
CO-09-2
Getting to know your IL-1 cytokines – the distinct roles of IL-1α and IL-1β – Kevin Eislmayr (Austria)
15.06
CO-10-2
Lung-specific innate immune memory controls reactivity of mononuclear phagocytes to acute and chronic inflammation – Natalie Katzmarski (Germany)
15.18
Salmonella persisters during infection – Peter Hill (United Kingdom)
15.48
Coffee break and poster viewing
16.15
Dendritic cells beyond antigen presentation – David Sancho (Spain)
16.45
CO-11-2
Resident macrophage subsets differentially impact bladder immunity to uropathogen infection – Livia Lacerda (France)
16.57
CO-12-2
Tuberculosis-driven expression of CD169 (Siglec-1) and localization in tunneling nanotubes leads to exacerbation of HIV-1 infection in human macrophages – Geanncarlo Lugo (France)
17.09
CO-13-2
Death Ligands Are Upregulated in Influenza Pneumonia and Contribute to the Apoptotic Depletion of the Resident Alveolar Macrophage Pool – Christina Malainou (Germany)
17.20
Non conventional immunity to the microbiota control tissue repair – Yasmine Belkaid (USA)
SESSION III – NEURO-IMMUNOLOGY (I)
Chairs: Helena Paidassi & Michael Sieweke
17.50
Harnessing the power of innate and adaptive immunity to combat Alzheimer’s Disease and Dementia – Michal Schwartz (Israel)
18.20 POSTER SESSION – ODD NUMBERS
19.30
Welcome cocktail
Friday, September 13th
08.00
Opening of the registration desk
SESSION III – NEUROIMMUNOLOGY (II)
Chairs: Helena Paidassi & Michael Sieweke
08.30
T cell-phagocyte interactions in Neuroinflammation – Burkhard Becher (Switzerland)
09.00
CO-14-3
Sensory neurons regulate dermal macrophage functions and tissue repair after skin exposure to UV radiation – Guillaume Hoeffel (France)
09.12
CO-15-3
Infection alters MHC II− and MHC II+ macrophage populations in the meninges which impairs CNS immunity – Rejane Rua (France)
09.24
Microglia in defense and disease during herpes simplex virus brain infection – Soren Paludan (Denmark)
SESSION IV – HOMEOSTASIS
Chairs: Marc Bajénoff & Julie Helft
09.54
CO-16-4
Colonic IL10Ra deficient macrophages at the apex of colitis initiation – Biana Bernshtein (Israel)
10.06
CO-17-4
Macrophages in distal colon form a unique type of trans-epithelial dendrites and are specialized to sample absorbed fluids – Aleksandra Chikina (France)
10.18
CO-18-4
Spatial mapping of macrophage heterogeneity in murine atherosclerotic plaques – Pieter Goossens (Netherlands)
10.30
Dissecting brain macrophage subpopulations – Steffen Jung (Israel)
11.00
Coffee break and poster viewing
11.30
In search of the potential macrophage niche – Martin Guilliams (Belgium)
12.00
CO-19-4
Dimerization partner shift of MafB determines macrophage polarization – Hao Huang (Germany)
12.12
CO-20-4
Protection against inflammatory diseases by rodent malaria is due to a virus that cripples DC function in a IFN-I-dependent manner.
Ali Hassan (France)
12.24
CO-21-4
A PIWI protein controls the replicative lifespan of alveolar macrophages – Stephanie Vargas Aguilar (Germany)
12.36
Macrophage niches: novel immunobiological functions of lymphoid stromal cells – Marc Bajénoff (France)
13.05
Lunch and poster viewing
14.00
CFCD General Assembly & EMDS Business Meeting
SESSION V – TISSUE REPAIR
Chairs: Vanja Sisirak & Sandrine Henri
14.30
Tissue resident macrophages: from development to old age – Elisa Gomez-Perdiguero (France)
15.00
New cross-talk between signaling pathways triggering the resolution of inflammation in macrophages – Bénédicte Chazaud (France)
15.30
CO-22-5
Understanding functional consequences of hepatic macrophage heterogeneity in NAFLD – Anneleen Remmerie (Belgium)
15.42
CO-23-5
Molecular dissection of macrophage control on tissue repair and regeneration – Petros Tzerpos (Hungary)
15.54
CO-24-5
Resident macrophages cloak tissue microlesions to prevent neutrophil-driven inflammatory damage – Stefan Uderhardt (USA)
16.05
Type 2 immunity, Macrophages & Tissue Repair – Judith Allen (United Kingdom)
16.35
EMDS Young researcher award talk
Chair: Thomas Decker
ZEB1 expression by cDC1s
is crucial for splenic macrophage
numbers and splenic cDC1
and cDC2 phenotype.
Charlotte Scott (Belgium)
17.00 POSTER SESSION – EVEN NUMBERS
18.30
EMDS Council meeting
19.00
Welcome desk for Gala dinner
20.00
Gala dinner – Palais de la bourse
9 La Canebière, 13001 Marseille
Saturday, September 14th
08.30
Opening of the registration desk
SESSION VI – TUMOR
Chairs: Toby Lawrence & Jenny Valladeau
09.00
Conserved Myeloid Cell Populations Across Individuals and Species – Mikael Pittet (USA)
09.30
CO-25-6
Jun regulates monocyte-derived macrophage accumulation and tumour progression – Marcello Delfini (France)
09.42
CO-26-6
Single cell mapping of human brain cancer reveals tumor-driven education of tumor-associated leukocytes – Ekaterina Friebel (Switzerland)
09.54
CO-27-6
Inflammasome-independent IL-1β release by myeloid cells in the tumor microenvironment promotes immune suppression and therapy resistance – Kiss Maté (Belgium)
10.06
CO-28-6
Mouse and human cutaneous squamous cell carcinomas harbor distinct dendritic cell subsets that can be reprogrammed by a local immunomodulatory treatment – Ophélie Vermeulen (France)
10.18
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in human breast cancer – Jenny Valladeau (France)
10.48
Coffee break and poster viewing
11.20
CO-29-6
High-Dimensional Single-Cell based functional immuno-metabolism by ZeNITH Identifies Conserved energetic programs in Human and Mouse myeloid cells – Rafael Arguello (France)
11.32
CO-30-6
Identification of two functionally distinct subsets of macrophages infiltrating human breast cancer – Rodrigo Ramos (France)
11.45
Immune Archetypes in Cancer and Myeloid Tuning Strategies – Matthew Krummel (USA)
12.15
Invitation to EMDS 2020 in Aarhus, Denmark
12.25
EMDS Awards ceremony & concluding remarks
13.15
End of the meeting